317 related items for PubMed ID: 24631042
1. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L, Li P, Xing CY, Zhao JY, He YN, Wang JQ, Wu XF, Liu ZS, Zhang AP, Lin HL, Ding XQ, Yin AP, Yuan FH, Fu P, Hao L, Miao LN, Xie RJ, Wang R, Zhou CH, Guan GJ, Hu Z, Lin S, Chang M, Zhang M, He LQ, Mei CL, Wang L, Chen X.
Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
[Abstract] [Full Text] [Related]
2. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
[Abstract] [Full Text] [Related]
3. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
Chen Y, Deng Y, Ni Z, Chen N, Chen X, Shi W, Zhan Y, Yuan F, Deng W, Zhong Y.
Am J Kidney Dis; 2013 Dec 11; 62(6):1068-76. PubMed ID: 23810688
[Abstract] [Full Text] [Related]
4. Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
Kou J, Wu J, Yang HT, He YN, Fang JA, Deng YY, Xie YS, Nie LF, Lin HL, Cai GY, Chen XM.
Trials; 2014 Dec 05; 15():479. PubMed ID: 25480673
[Abstract] [Full Text] [Related]
5. Treatment of chronic kidney disease using a traditional Chinese medicine, Flos Abelmoschus manihot (Linnaeus) Medicus (Malvaceae).
Chen Y, Cai G, Sun X, Chen X.
Clin Exp Pharmacol Physiol; 2016 Feb 05; 43(2):145-8. PubMed ID: 26667396
[Abstract] [Full Text] [Related]
6. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.
Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, Zhang PQ, Wei LB, Cao SL, Yang NZ, Ma HZ, Gao J, Li P, Tao XJ, Yuan FH, Li J, Yao C, Liu X.
J Ethnopharmacol; 2012 Feb 15; 139(3):757-64. PubMed ID: 22178174
[Abstract] [Full Text] [Related]
7. Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial.
Li P, Lin H, Ni Z, Zhan Y, He Y, Yang H, Fang J, Wang N, Li W, Cai G, Chen Y, Zhang P, Wang X, Chen Q, Li Z, Sun X, Chen X.
Phytomedicine; 2020 May 18; 76():153231. PubMed ID: 32535481
[Abstract] [Full Text] [Related]
8. [Syndrome differentiation-based treatment with traditional Chinese medicine for proteinuria in patients with chronic kidney disease: a randomized multicenter trial].
Wang D, Wu T, Xie T, Peng W, Wang Y, Yuan M, Mi X, Bi Y, He L.
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr 18; 33(4):502-6. PubMed ID: 23644107
[Abstract] [Full Text] [Related]
9. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Wu J, Duan SW, Yang HT, Deng YY, Li W, He YN, Ni ZH, Zhan YL, Lin S, Guo ZY, Zhu J, Fang JA, Liu XS, Wang LH, Wang R, Wang NS, Cheng XH, He LQ, Luo P, Sun SR, Sun JF, Yin AP, Jiang GR, Chen HY, Liu WH, Lin HL, Liang M, Ma L, Chen M, Song LQ, Chen J, Zhu Q, Xing CY, Li Y, Gao JN, Li RS, Li Y, Zhang H, Lu Y, Zhou QL, Fu JZ, He Q, Cai GY, Chen XM.
J Integr Med; 2021 Mar 18; 19(2):111-119. PubMed ID: 33589406
[Abstract] [Full Text] [Related]
10. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF.
Phytother Res; 2021 Jan 18; 35(1):198-206. PubMed ID: 32716080
[Abstract] [Full Text] [Related]
11. Glomerular disease. Antiproteinuric efficacy of A. manihot superior to losartan.
Carney EF.
Nat Rev Nephrol; 2014 Jun 18; 10(6):300. PubMed ID: 24709846
[No Abstract] [Full Text] [Related]
12. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL, Chen YM, Chiang WC, Wu KD, Tsai TJ.
Am J Kidney Dis; 2008 Sep 18; 52(3):464-74. PubMed ID: 18617301
[Abstract] [Full Text] [Related]
13. [Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].
Chen P, Wan Y, Wang C, Zhao Q, Wei Q, Tu Y, Yin X.
Zhongguo Zhong Yao Za Zhi; 2012 Aug 18; 37(15):2252-6. PubMed ID: 23189729
[Abstract] [Full Text] [Related]
14. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, ameliorates adriamycin-induced renal inflammation and glomerular injury via inhibiting p38MAPK signaling pathway activity in rats.
Tu Y, Sun W, Wan YG, Che XY, Pu HP, Yin XJ, Chen HL, Meng XJ, Huang YR, Shi XM.
J Ethnopharmacol; 2013 May 20; 147(2):311-20. PubMed ID: 23518420
[Abstract] [Full Text] [Related]
15. [Multi-center randomized control study on the effects of syndrome differentiated traditional Chinese medicine therapy on CKD 1-2 with chronic nephritis proteinuria].
Wu F, Zhang PQ, Wang XQ, Nie LF, Fu XJ, Peng W, Wang Y, Li J, Bi YP, Mi XH, Ding XQ, He LQ.
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan 20; 46(1):145-8. PubMed ID: 25807814
[Abstract] [Full Text] [Related]
16. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J, Miao JJ, Sun XY, Yu JY.
J Ethnopharmacol; 2016 Aug 02; 189():238-49. PubMed ID: 27224243
[Abstract] [Full Text] [Related]
17. [Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study].
Fang YQ, Lu Y, Wang YJ.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar 02; 32(3):311-6. PubMed ID: 22686073
[Abstract] [Full Text] [Related]
18. Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study.
Zheng Y, Cai GY, He LQ, Lin HL, Cheng XH, Wang NS, Jian GH, Liu XS, Liu YN, Ni ZH, Fang JA, Ding HL, Guo W, He YN, Wang LH, Wang YP, Yang HT, Ye ZM, Yu RH, Zhao LJ, Zhou WH, Li WG, Mao HJ, Zhan YL, Hu Z, Yao C, Wei RB, Chen XM.
Chin Med J (Engl); 2017 Oct 20; 130(20):2402-2409. PubMed ID: 29052559
[Abstract] [Full Text] [Related]
19. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S, Li JP.
Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
[Abstract] [Full Text] [Related]
20. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
Li P, Chen Y, Liu J, Hong J, Deng Y, Yang F, Jin X, Gao J, Li J, Fang H, Liu G, Shi L, Du J, Li Y, Yan M, Wen Y, Yang W.
PLoS One; 2015 Jan 06; 10(5):e0126027. PubMed ID: 25938778
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
